| Application no. and date | 08152489.4 (espacenet) (Federated) (European Patent Register), 20030515 | | Patent/reg. no. and date | DK/EP 1944026, 20130626 | | Publication date | 20080716 | | Priority no. and date | GB 0211261, 20020516, US 390411 P, 20020620, GB 0217150, 20020724, US 449739 P, 20030224 | | EP pub. no. and date |
EP 1944026 20080716 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | NGC/AP/147547 | | Inventor | Baumruker, Thomas,
Gumpoldskirchner Strasse 26/3
A 2340, Moedling, AT,
Brinkmann, Volker,
Sternwaldstrasse 31
79102, Freiburg, DE,
Mechtcheriakova, Diana,
Fasangartengasse 30/1/4
A 1130, Wien, AT,
Wood, Jeanette Marjorie,
In den Kleematten 18
CH 4105, Biel-Benken, CH,
La Montagne, Kenneth Richard,
6 Albert Avenue
Morristown, NJ 07960, US,
Lassota, Peter T,
99 South Hillside Avenue
Succasunna, NJ 07876, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 31/135 (2006.01) , A61K 31/381 (2006.01) , A61P 35/00 (2006.01) | | Title | Anvendelse af EDG-receptorbindingsmidler ved cancer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
